Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Amrion

This article was originally published in The Tan Sheet

Executive Summary

Pleads guilty June 22 to 1989 violation of FD&C Act and agrees to pay $46,000 fine, settling an investigation by FDA and the Department of Justice ("The Tan Sheet" June 6, In Brief). Known in 1989 as Bioenergy Nutrients, the company introduced into interstate commerce 751 units of Co-Enzyme Q10 that were "misbranded" because of "promotional materials that contained therapeutic claims," according to the plea agreement. In a June 23 press release, Amrion emphasized that the activities in question "occurred five and six years ago when the company was in its infancy and under different management"

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS082931

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel